Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Vaccine|November 13, 2016
Knowledge, attitudes and practices of Australian medical students towards influenza vaccinationLuke Walker, Anthony Newall, Anita E HeywoodJournal of Applied Clinical Medical Physics|November 21, 2008
Simulation of intrafraction motion and overall geometrical accuracy of a frameless intracranial radiosurgery processVladimir Feygelman, Luke Walker, Prakash Chinnaiyan, et al.Plos One|February 6, 2013
The flux-based PIN allocation mechanism can generate either canalyzed or diffuse distribution patterns depending on geometry and boundary conditionsMichael Luke Walker, Etienne Farcot, Jan Traas, et al.Annals of Medicine and Surgery (2012)|March 20, 2025
<i>Haemophilus influenzae</i>-induced epididymitis: a rare case reportDev Patel, Luke Walker, Nalini Patel, et al.Journal of Applied Clinical Medical Physics|August 19, 2010
Validation of Pinnacle treatment planning system for use with Novalis delivery unitVladimir Faygelman, Dylan Hunt, Luke Walker, et al.Proceedings of the National Academy of Sciences of the United States of America|November 19, 2004
Transplanted human bone marrow contributes to vascular endotheliumShuguang Jiang, Luke Walker, Michael Afentoulis, et al.Investigational New Drugs|June 12, 2014
A multicenter phase 1 study of PX-866 and cetuximab in patients with metastatic colorectal carcinoma or recurrent/metastatic squamous cell carcinoma of the head and neckDaniel W Bowles, Neil Senzer, Diana Hausman, et al.Medical Physics|January 10, 2012
Evaluating dosimetric accuracy of flattening filter free compensator-based IMRT: measurements with diode arraysJoshua Robinson, Daniel Opp, Geoffrey Zhang, et al.Clinical Pharmacokinetics|August 5, 2022
Evaluation of Safety and Clinically Relevant Drug-Drug Interactions with Tucatinib in Healthy VolunteersAriel Topletz-Erickson, Anthony Lee, Evelyn L Rustia, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancerBenjamin Levy, Alexander Spira, Daniel Becker, et al.Pageof 2